查看購物車
  • English
  • Japanese
  • Korean
2026-2030年全球抗菌藥物敏感性測試市場
市場調查報告書
商品編碼
2078080

2026-2030年全球抗菌藥物敏感性測試市場

Global Antimicrobial Susceptibility Testing Market 2026-2030
出版日期: | 出版商: TechNavio | 英文 309 Pages | 訂單完成後即時交付

價格
簡介目錄

全球抗菌藥物敏感性測試市場預計將從 2025 年到 2030 年成長至 13.241 億美元，預測期內複合年成長率為 5.2%。

本報告對全球抗菌藥物敏感性測試市場進行了全面分析，包括市場規模和預測、趨勢、成長要素、挑戰以及涵蓋約 25 家供應商的供應商分析。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。推動該市場發展的因素包括：日益嚴重的全球抗菌素抗藥性問題、診斷平台技術的加速創新，以及人們對抗菌素減量計畫和全球健康舉措日益成長的關注。

本研究客觀地結合了一手和二手訊息，包括主要行業相關人員的意見。報告內容涵蓋主要公司分析、全面的市場規模數據、區域細分分析以及供應商格局。報告包含歷史數據和預測數據。

市場範圍
基準年 2025
年末 2030
調查期 2026-2030
成長勢頭 加速度
與 2026 年相比 5%
複合年成長率 5.2%
增量 13.241億美元

本研究指出，未來幾年全球抗菌藥物敏感性檢測市場成長的主要驅動力之一是檢測平台向快速自動化方向的模式轉移。此外，人工智慧和先進數據分析技術的融合，以及無需培養的「直接檢體檢測」方法的普及，預計也將顯著提升市場需求。

目錄

第1章執行摘要

第2章 Technavio 分析

  • 分析定價、生命週期、顧客購買籃子、採用率和購買標準。
  • 輸入的重要性及差異化因素
  • 干擾因素
  • 促進因素和挑戰的影響

第3章 市場狀況

  • 市場生態系統
  • 市場特徵
  • 價值鏈分析

第4章 市場規模

  • 市場的定義
  • 市場區隔分析
  • 2025年市場規模
  • 市場展望，2025-2030年

第5章 市場規模與表現

  • 2020-2024年全球抗菌藥物敏感性檢測市場
  • 按類型分類的細分市場分析，2020-2024 年
  • 基於應用領域的細分市場分析，2020-2024 年
  • 2020-2024 年最終用戶細分市場分析
  • 區域區隔市場分析，2020-2024 年
  • 2020-2024年各國細分市場分析

第6章 定性分析

  • 人工智慧的影響：全球抗菌藥物敏感性測試市場
  • 地緣政治衝突的影響：全球抗菌藥物敏感性檢測市場

第7章：五力分析

第8章 市場區隔：依類型

  • 比較：按類型
  • 抗菌藥物測試
  • 抗真菌試驗
  • 抗寄生蟲檢測
  • 抗病毒檢測
  • 市場機會：按類型分類

第9章 市場區隔：依應用

  • 比較：透過應用
  • 臨床診斷
  • 藥物發現和藥物開發
  • 其他
  • 市場機會：依應用領域分類

第10章 市場區隔：依最終用戶分類

  • 比較：按最終用戶
  • 醫院和診所
  • 臨床實驗室
  • 製藥和生物技術公司
  • 其他
  • 市場機會：依最終用戶分類

第11章 客戶情況

第12章 區域情勢

  • 區域分類
  • 區域比較
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
  • 亞洲
    • 中國
    • 日本
    • 印度
    • 韓國
    • 新加坡
    • 泰國
  • 世界其他地區（RoW）
    • 巴西
    • 沙烏地阿拉伯
    • 南非
    • UAE
    • 阿根廷
    • 智利
    • 埃及
    • 土耳其
  • 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

  • 市場促進因素
  • 市場挑戰
  • 促進因素和挑戰的影響
  • 市場機遇

第14章 競爭格局

  • 概述
  • 競爭格局
  • 混亂局面
  • 產業風險

第15章 競爭分析

  • 公司簡介
  • 公司排名指標
  • 企業市場定位
  • ALIFAX Srl
  • Beckman Coulter Inc.
  • Becton Dickinson and Co.
  • Bio Rad Laboratories Inc.
  • BioMerieux SA
  • Bruker Corp.
  • COPAN ITALIA spa
  • Creative Diagnostics
  • DL Biotech
  • ELITechGroup SAS
  • F. Hoffmann La Roche Ltd.
  • HiMedia Laboratories Pvt. Ltd.
  • Merck KGaA
  • Sysmex Corp.
  • Thermo Fisher Scientific Inc.

第16章附錄

簡介目錄
Product Code: IRTNTR41650

The global antimicrobial susceptibility testing market is forecasted to grow by USD 1324.1 mn during 2025-2030, accelerating at a CAGR of 5.2% during the forecast period. The report on the global antimicrobial susceptibility testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by escalating global crisis of antimicrobial resistance, accelerated technological innovation in diagnostic platforms, increased emphasis on antimicrobial stewardship programs and global health initiatives.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Market Scope
Base Year2025
End Year2030
Series Year2026-2030
Growth MomentumAccelerate
YOY 20265%
CAGR5.2%
Incremental Value$1324.1 mn

Technavio's global antimicrobial susceptibility testing market is segmented as below:

By Type

  • Antibacterial testing
  • Antifungal testing
  • Antiparasitic testing
  • Antiviral testing

By Application

  • Clinical diagnostics
  • Drug discovery and development
  • Others

By End-User

  • Hospitals and clinics
  • Clinical laboratories
  • Pharmaceutical and biotechnology companies
  • Others

Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • The Netherlands
  • Asia
  • Rest of World (ROW)
  • Rest of World (ROW)

This study identifies the paradigm shift toward rapid and automated testing platforms as one of the prime reasons driving the global antimicrobial susceptibility testing market growth during the next few years. Also, integration of ai and advanced data analytics and pursuit of culture-independent, direct-from-sample testing will lead to sizable demand in the market.

The report on the global antimicrobial susceptibility testing market covers the following areas:

  • Global antimicrobial susceptibility testing market sizing
  • Global antimicrobial susceptibility testing market forecast
  • Global antimicrobial susceptibility testing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global antimicrobial susceptibility testing market vendors that include ALIFAX Srl, Beckman Coulter Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Bio Senker Biotechnology Co Ltd, BioMerieux SA, Bruker Corp., COPAN ITALIA spa, Creative Diagnostics, DL Biotech, ELITechGroup SAS, F. Hoffmann La Roche Ltd., FASTinov SA, Hardy Diagnostics, HiMedia Laboratories Pvt. Ltd., Liofilchem Srl, Mast Group Ltd., Merck KGaA, Sysmex Corp., Thermo Fisher Scientific Inc.. Also, the global antimicrobial susceptibility testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market by Geography
    • Executive Summary - Chart on Market Segmentation by Type
    • Executive Summary - Chart on Market Segmentation by Application
    • Executive Summary - Chart on Market Segmentation by End-user
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
  • 2.3 Factors of disruption
  • 2.4 Impact of drivers and challenges

3 Market Landscape

  • 3.1 Market ecosystem
  • 3.2 Market characteristics
  • 3.3 Value chain analysis

4 Market Sizing

  • 4.1 Market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2025
  • 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

  • 5.1 Global Antimicrobial Susceptibility Testing Market 2020 - 2024
    • Historic Market Size - Data Table on Global Antimicrobial Susceptibility Testing Market 2020 - 2024 ($ million)
  • 5.2 Type segment analysis 2020 - 2024
    • Historic Market Size - Type Segment 2020 - 2024 ($ million)
  • 5.3 Application segment analysis 2020 - 2024
    • Historic Market Size - Application Segment 2020 - 2024 ($ million)
  • 5.4 End-user segment analysis 2020 - 2024
    • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
  • 5.5 Geography segment analysis 2020 - 2024
    • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
  • 5.6 Country segment analysis 2020 - 2024
    • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

  • 6.1 Impact of AI on Global Antimicrobial Susceptibility Testing Market
  • 6.2 Impact of Geopolitical Conflicts on Global Antimicrobial Susceptibility Testing Market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2025 and 2030
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2025 and 2030
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2025 and 2030
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2025 and 2030
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2025 and 2030
  • 7.7 Market condition

8 Market Segmentation by Type

  • 8.1 Market segments
  • 8.2 Comparison by Type
  • 8.3 Antibacterial testing - Market size and forecast 2025-2030
  • 8.4 Antifungal testing - Market size and forecast 2025-2030
  • 8.5 Antiparasitic testing - Market size and forecast 2025-2030
  • 8.6 Antiviral testing - Market size and forecast 2025-2030
  • 8.7 Market opportunity by Type
    • Market opportunity by Type ($ million)

9 Market Segmentation by Application

  • 9.1 Market segments
  • 9.2 Comparison by Application
  • 9.3 Clinical diagnostics - Market size and forecast 2025-2030
  • 9.4 Drug discovery and development - Market size and forecast 2025-2030
  • 9.5 Others - Market size and forecast 2025-2030
  • 9.6 Market opportunity by Application
    • Market opportunity by Application ($ million)

10 Market Segmentation by End-user

  • 10.1 Market segments
  • 10.2 Comparison by End-user
  • 10.3 Hospitals and clinics - Market size and forecast 2025-2030
  • 10.4 Clinical laboratories - Market size and forecast 2025-2030
  • 10.5 Pharmaceutical and biotechnology companies - Market size and forecast 2025-2030
  • 10.6 Others - Market size and forecast 2025-2030
  • 10.7 Market opportunity by End-user
    • Market opportunity by End-user ($ million)

11 Customer Landscape

  • 11.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

  • 12.1 Geographic segmentation
  • 12.2 Geographic comparison
  • 12.3 North America - Market size and forecast 2025-2030
    • 12.3.1 US - Market size and forecast 2025-2030
    • 12.3.2 Canada - Market size and forecast 2025-2030
    • 12.3.3 Mexico - Market size and forecast 2025-2030
  • 12.4 Europe - Market size and forecast 2025-2030
    • 12.4.1 Germany - Market size and forecast 2025-2030
    • 12.4.2 UK - Market size and forecast 2025-2030
    • 12.4.3 France - Market size and forecast 2025-2030
    • 12.4.4 Italy - Market size and forecast 2025-2030
    • 12.4.5 Spain - Market size and forecast 2025-2030
    • 12.4.6 The Netherlands - Market size and forecast 2025-2030
  • 12.5 Asia - Market size and forecast 2025-2030
    • 12.5.1 China - Market size and forecast 2025-2030
    • 12.5.2 Japan - Market size and forecast 2025-2030
    • 12.5.3 India - Market size and forecast 2025-2030
    • 12.5.4 South Korea - Market size and forecast 2025-2030
    • 12.5.5 Singapore - Market size and forecast 2025-2030
    • 12.5.6 Thailand - Market size and forecast 2025-2030
  • 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
    • 12.6.1 Brazil - Market size and forecast 2025-2030
    • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
    • 12.6.3 South Africa - Market size and forecast 2025-2030
    • 12.6.4 UAE - Market size and forecast 2025-2030
    • 12.6.5 Argentina - Market size and forecast 2025-2030
    • 12.6.6 Chile - Market size and forecast 2025-2030
    • 12.6.7 Egypt - Market size and forecast 2025-2030
    • 12.6.8 Turkey - Market size and forecast 2025-2030
  • 12.7 Market opportunity by geography
    • Market opportunity by geography ($ million)
    • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

  • 13.1 Market drivers
    • Escalating global crisis of antimicrobial resistance
    • Accelerated technological innovation in diagnostic platforms
    • Increased emphasis on antimicrobial stewardship programs and global health initiatives
  • 13.2 Market challenges
    • High cost and implementation complexity of advanced testing platforms
    • Challenges in adoption and integration of rapid diagnostic technologies
    • Navigating complex and evolving regulatory and reimbursement landscape
  • 13.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2025 and 2030
  • 13.4 Market opportunities
    • Paradigm shift toward rapid and automated testing platforms
    • Integration of AI and advanced data analytics
    • Pursuit of culture-independent, direct-from-sample testing

14 Competitive Landscape

  • 14.1 Overview
  • 14.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 14.3 Landscape disruption
    • Overview on factors of disruption
  • 14.4 Industry risks
    • Impact of key risks on business

15 Competitive Analysis

  • 15.1 Companies profiled
    • Companies covered
  • 15.2 Company ranking index
    • Company ranking index
  • 15.3 Market positioning of companies
    • Matrix on companies position and classification
  • 15.4 ALIFAX Srl
    • ALIFAX Srl - Overview
    • ALIFAX Srl - Product / Service
    • ALIFAX Srl - Key offerings
    • SWOT
  • 15.5 Beckman Coulter Inc.
    • Beckman Coulter Inc. - Overview
    • Beckman Coulter Inc. - Product / Service
    • Beckman Coulter Inc. - Key offerings
    • SWOT
  • 15.6 Becton Dickinson and Co.
    • Becton Dickinson and Co. - Overview
    • Becton Dickinson and Co. - Business segments
    • Becton Dickinson and Co. - Key offerings
    • Becton Dickinson and Co. - Segment focus
    • SWOT
  • 15.7 Bio Rad Laboratories Inc.
    • Bio Rad Laboratories Inc. - Overview
    • Bio Rad Laboratories Inc. - Business segments
    • Bio Rad Laboratories Inc. - Key news
    • Bio Rad Laboratories Inc. - Key offerings
    • Bio Rad Laboratories Inc. - Segment focus
    • SWOT
  • 15.8 BioMerieux SA
    • BioMerieux SA - Overview
    • BioMerieux SA - Business segments
    • BioMerieux SA - Key offerings
    • BioMerieux SA - Segment focus
    • SWOT
  • 15.9 Bruker Corp.
    • Bruker Corp. - Overview
    • Bruker Corp. - Business segments
    • Bruker Corp. - Key offerings
    • Bruker Corp. - Segment focus
    • SWOT
  • 15.10 COPAN ITALIA spa
    • COPAN ITALIA spa - Overview
    • COPAN ITALIA spa - Product / Service
    • COPAN ITALIA spa - Key offerings
    • SWOT
  • 15.11 Creative Diagnostics
    • Creative Diagnostics - Overview
    • Creative Diagnostics - Product / Service
    • Creative Diagnostics - Key offerings
    • SWOT
  • 15.12 DL Biotech
    • DL Biotech - Overview
    • DL Biotech - Product / Service
    • DL Biotech - Key offerings
    • SWOT
  • 15.13 ELITechGroup SAS
    • ELITechGroup SAS - Overview
    • ELITechGroup SAS - Product / Service
    • ELITechGroup SAS - Key offerings
    • SWOT
  • 15.14 F. Hoffmann La Roche Ltd.
    • F. Hoffmann La Roche Ltd. - Overview
    • F. Hoffmann La Roche Ltd. - Business segments
    • F. Hoffmann La Roche Ltd. - Key news
    • F. Hoffmann La Roche Ltd. - Key offerings
    • F. Hoffmann La Roche Ltd. - Segment focus
    • SWOT
  • 15.15 HiMedia Laboratories Pvt. Ltd.
    • HiMedia Laboratories Pvt. Ltd. - Overview
    • HiMedia Laboratories Pvt. Ltd. - Product / Service
    • HiMedia Laboratories Pvt. Ltd. - Key offerings
    • SWOT
  • 15.16 Merck KGaA
    • Merck KGaA - Overview
    • Merck KGaA - Business segments
    • Merck KGaA - Key news
    • Merck KGaA - Key offerings
    • Merck KGaA - Segment focus
    • SWOT
  • 15.17 Sysmex Corp.
    • Sysmex Corp. - Overview
    • Sysmex Corp. - Business segments
    • Sysmex Corp. - Key news
    • Sysmex Corp. - Key offerings
    • Sysmex Corp. - Segment focus
    • SWOT
  • 15.18 Thermo Fisher Scientific Inc.
    • Thermo Fisher Scientific Inc. - Overview
    • Thermo Fisher Scientific Inc. - Business segments
    • Thermo Fisher Scientific Inc. - Key news
    • Thermo Fisher Scientific Inc. - Key offerings
    • Thermo Fisher Scientific Inc. - Segment focus
    • SWOT

16 Appendix

  • 16.1 Scope of the report
    • Market definition
    • Objectives
    • Notes and caveats
  • 16.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 16.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 16.4 Research methodology
    • Research methodology
  • 16.5 Data procurement
    • Information sources
  • 16.6 Data validation
    • Data validation
  • 16.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 16.8 Data synthesis
    • Data synthesis
  • 16.9 360 degree market analysis
    • 360 degree market analysis
  • 16.10 List of abbreviations
    • List of abbreviations